GLP-1s and Blood Sugar When You Don’t Have Diabetes
What GLP-1 prescribing information says about low blood sugar in adults without diabetes, which symptoms need prompt care, and what to ask your clinician.
On this page
The short answer
Low blood sugar (hypoglycemia) has been reported with GLP-1 medicines in adults without diabetes, but the prescribing information does not give a reliable rate: Wegovy’s trials did not systematically record it, and Zepbound’s weight trial in adults without diabetes did not either. Risk is higher with insulin or sulfonylureas and after bariatric surgery. Shakiness, sweating, confusion, or fainting need prompt care, not waiting.
What low blood sugar symptoms need care right now?
Low blood sugar symptoms tend to come on quickly and can include shaking, sweating, nervousness or anxiety, irritability or confusion, dizziness, and hunger. 1 If you are taking a GLP-1 and notice these, contact your prescriber or care team promptly. Do not assume the cause is your medicine, your meal timing, or stress.
Severe low blood sugar can cause passing out, coma, or even death. 1 Fainting, being unable to stay awake, or being too confused to help yourself needs emergency care. If someone with you has these signs, call 911 rather than waiting to see whether they pass. This page cannot tell you whether your own symptoms are harmless, and no one should tell you that without checking your glucose and history.
Can a GLP-1 cause low blood sugar if you don’t have diabetes?
Yes, it has been reported. Wegovy’s prescribing information says episodes of hypoglycemia have been reported with GLP-1 receptor agonists in adults without type 2 diabetes. 2 Zepbound’s says the same. 3
These medicines raise insulin release in a glucose-dependent way, meaning the effect depends on how much glucose is in your blood. 2 3 That does not mean the risk is zero, and the labels report hypoglycemia anyway.
How common is it? What do the labels actually show?
The honest answer is that the evidence does not settle it for people without diabetes. Here is what each label states.
| Question | Wegovy (semaglutide) | Zepbound (tirzepatide) |
|---|---|---|
| Was low blood sugar systematically recorded in weight trials of adults without diabetes? | No. 2 | No. 3 |
| What was reported anyway? | In a cardiovascular outcomes trial in adults without diabetes, 3 serious episodes with Wegovy versus 1 with placebo. 2 | In the weight trial in adults without diabetes, glucose below 54 mg/dL in 0.3% of Zepbound patients and none on placebo. 3 |
| Higher-risk situations named | Insulin or a sulfonylurea; history of bariatric surgery. 2 | Insulin or a sulfonylurea. 3 |
Read these as signals, not rates. The trials were not designed to measure this outcome in people without diabetes, so no figure here tells you your own chance. In the Wegovy trial, adults with a history of bariatric surgery, a recognized risk factor for hypoglycemia, had more serious episodes on Wegovy (2 of 87) than on placebo (0 of 97), a small group that supports caution but not a rate. 2
These are branded, FDA-approved products. Evidence for them does not transfer to compounded preparations, which are not FDA-approved.
Who is more likely to have low blood sugar for other reasons?
Low blood sugar without diabetes is uncommon. Causes can include liver disease, kidney disease, hormone deficiencies, certain weight loss surgeries, and some medicines. 1 Drinking too much alcohol without enough food, or being sick and unable to keep food down, can also lower glucose in general. 1
That list matters because several of these can overlap with GLP-1 treatment. Eating much less is an expected effect of these medicines, and it is a reason to tell your clinician about any shakiness or confusion rather than a reason to dismiss it.
What should you bring to your appointment?
A short list helps your prescriber judge risk before you start and at follow-up. It does not diagnose anything.
| Bring or tell them | Why it matters |
|---|---|
| Every diabetes medicine, including insulin and sulfonylureas | Combined use raises hypoglycemia risk in both labels. 2 3 |
| Any history of bariatric surgery | Named as a risk factor in Wegovy’s label. 2 |
| Liver, kidney, or hormone conditions | Recognized causes of low blood sugar. 1 |
| How much alcohol you drink and how much you are eating | Alcohol without food and not eating enough can lower glucose. 1 |
| A dated note of any shaky, sweaty, or confused episodes, and what you had eaten | Helps your clinician decide whether to check glucose. |
What can a clinician do about it?
If you do not have diabetes and keep having low blood sugar, treatment depends on what is causing it. 1 Your clinician may order tests to find the cause, and whether your GLP-1 plan should change is their decision. 1 Do not change or stop a prescribed medicine on your own because of a symptom; call your prescriber instead.
For the wider picture of what to watch for, see our guide to GLP-1 side effects and when to get help. For which tests a clinician may discuss first, read what lab tests a clinician might discuss before GLP-1 treatment. If you are new to these medicines, our GLP-1 starting guide explains how they work and who prescribes them.
Common questions
Does a GLP-1 control blood sugar the same way in people without diabetes?
These medicines act on insulin and glucagon in a glucose-dependent way. 2 3 The labels do not describe a measured glucose effect for adults without diabetes in their weight trials, so this page makes no claim about it.
Should I check my glucose at home?
That is a question for your prescriber. The labels advise glucose monitoring for people with diabetes, and do not give monitoring instructions for adults without it. 3
References
- Hypoglycemia — MedlinePlus, National Library of Medicine
- Wegovy (semaglutide) Prescribing Information — Novo Nordisk
- Zepbound (tirzepatide) Prescribing Information — Eli Lilly and Company
For your information. This article provides general education and does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.